Delivery Order SPE2DB22D1106-SPE2DB25FFDA3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,113.19 to AmerisourceBergen Drug Corp for 10,000 units of chorionic gonadotropin (a hormone treatment) on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price, non-set-aside contract represents a competitive award to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $10,497.90 firm fixed price delivery order to Amerisourcebergen Drug Corp for 10,000 units of chorionic gonadotropin. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products to its place of performance in Conshohocken, Pennsylvania by September 7, 2023 to fulfill requirements under the contract. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution vehicles...
- The Defense Logistics Agency awarded a $315 delivery order to Amerisourcebergen Drug Corporation for 10,000 units of chorionic gonadotropin. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location to support the Defense Logistics Agency's medical supply needs. No major subcontractors or set aside designations were identified. The one-day period of performance from July 5 to July 6, 2023 suggests this delivery order was placed under the DLA's...
- The Defense Logistics Agency awarded a $31,639.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product used in fertility treatment. The award, issued on June 20, 2025, with an ultimate completion date of June 23, 2025, represents a non-competitive delivery order. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- This federal contract award is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 10,000 units of Chorionic Gonad, a medical product, with a ceiling value of $5,473.80. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 7, 2025. The contract is a firm fixed price type and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of 10,000 units of chorionic gonad with a ceiling value of $3,692.80. This contract represents a non-set-aside, competitively awarded delivery order utilizing firm fixed price terms, with an ultimate completion date of August 20, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pregnyl 10,000 Unit Vials, a human chorionic gonadotropin pharmaceutical product. This firm fixed-price delivery order, valued at $1,813.50, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a $10,975 delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a fertility medication used in assisted reproductive treatments. This firm fixed price delivery order, issued on April 10, 2025, with an ultimate completion date of April 11, 2025, represents a non-set-aside competitive award. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $6,306.20 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 10,000 units of chorionic gonadotropin. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by December 14, 2023. No set-aside designation was applied to this award made against an indefinite-delivery contract held by Amerisourcebergen...
- The Defense Logistics Agency awarded a $21,950 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF Redi-Ject 900 Unit 1.44ML, a pharmaceutical product used in fertility treatment. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and is not designated as a set-aside contract. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDA3Delivery Order
The Defense Logistics Agency awarded a $5,985.23 delivery order to AmerisourceBergen Drug Corp for 10,000 units of chorionic gonadotropin, a hormone-based pharmaceutical product commonly used in fertility treatments and medical therapies. The contract, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed-price procurement under a competitively awarded arrangement with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, the corporate headquarters location of AmerisourceBergen Drug Corp. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp supplies pharmaceuticals and medical commodities to support military healthcare programs, the Defense Health Agency, and other government healthcare systems. The firm's track record of delivering diverse pharmaceutical products through competitively awarded contracts demonstrates its capability to fulfill specialized medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 8/13/25 |